Kardigan, Inc. (KARD)
Nasdaq: KARD · Pharmaceutical Preparations · filing with the SEC since 2026
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal quarter | Q3 FY26 | Q2 FY26 |
|---|---|---|
| Period ending | Sep 30, 2026 | Jun 30, 2026 |
| Report filed | Nov 12, 2026 | Aug 11, 2026 |
| Research and development | 64,359 | 56,365 |
| General and administrative | 22,245 | 18,867 |
| Total operating expenses | 64,815 | 118,761 |
| Operating income | -64,815 | -118,761 |
| Interest and investment income | 6,236 | 2,765 |
| Other income (expense), net | -6,247 | -2,525 |
| Income before income taxes | -58,568 | -116,236 |
| Income tax expense | 0 | 0 |
| Net income | -58,568 | -116,236 |
| Net income to common shareholders | · | -116,236 |
| Earnings per share, basic | -0.64 | -4.61 |
| Earnings per share, diluted | -0.64 | -4.61 |
| Weighted average shares, basic | 92,072,013 | 25,196,212 |
| Weighted average shares, diluted | 92,072,013 | 25,196,212 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Each quarter is three months. A fourth quarter prints only where the company tagged its three months on their own; the whole year is in the annual view.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding